PT1390371E - Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores - Google Patents
Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumoresInfo
- Publication number
- PT1390371E PT1390371E PT02740590T PT02740590T PT1390371E PT 1390371 E PT1390371 E PT 1390371E PT 02740590 T PT02740590 T PT 02740590T PT 02740590 T PT02740590 T PT 02740590T PT 1390371 E PT1390371 E PT 1390371E
- Authority
- PT
- Portugal
- Prior art keywords
- furopyrimidines
- oxazolo
- against tumors
- medicines against
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH8732001 | 2001-05-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1390371E true PT1390371E (pt) | 2006-07-31 |
Family
ID=4544205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT02740590T PT1390371E (pt) | 2001-05-14 | 2002-05-13 | Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores |
Country Status (12)
Country | Link |
---|---|
US (1) | US7294633B2 (pt) |
EP (1) | EP1390371B1 (pt) |
JP (1) | JP4155827B2 (pt) |
CN (1) | CN100378107C (pt) |
AT (1) | ATE319718T1 (pt) |
BR (1) | BR0209645A (pt) |
CA (1) | CA2449188A1 (pt) |
DE (1) | DE60209721T2 (pt) |
DK (1) | DK1390371T3 (pt) |
ES (1) | ES2259707T3 (pt) |
PT (1) | PT1390371E (pt) |
WO (1) | WO2002092603A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1689753A4 (en) * | 2003-12-04 | 2010-07-07 | Glaxosmithkline Llc | NEW CHEMICAL COMPOUNDS |
KR20050091462A (ko) * | 2004-03-12 | 2005-09-15 | 한국과학기술연구원 | 푸로피리미딘 화합물 및 이를 포함하는 ddr2 티로신키나아제 활성 저해제 |
EP1731523A4 (en) * | 2004-04-01 | 2009-08-12 | Takeda Pharmaceutical | THIAZOLOPYRIMIDINE DERIVATIVE |
WO2006114180A1 (de) | 2005-04-25 | 2006-11-02 | Merck Patent Gmbh | Neuartige aza-heterozyklen als kinase-inhibitoren |
DE102005061171A1 (de) | 2005-12-21 | 2007-07-05 | Bayer Healthcare Ag | Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung |
DE102005061170A1 (de) | 2005-12-21 | 2007-07-05 | Bayer Healthcare Ag | Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung |
CN103494815A (zh) * | 2006-06-22 | 2014-01-08 | 日本化学医药株式会社 | 抗癌药耐性克服剂 |
DE102007019691A1 (de) | 2007-04-26 | 2008-10-30 | Bayer Healthcare Ag | Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie |
DE102007019690A1 (de) * | 2007-04-26 | 2008-10-30 | Bayer Healthcare Ag | Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie |
DE102007027800A1 (de) | 2007-06-16 | 2008-12-18 | Bayer Healthcare Ag | Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung |
DE102007027799A1 (de) | 2007-06-16 | 2008-12-18 | Bayer Healthcare Ag | Substituierte Furopyrimidine und ihre Verwendung |
NZ590377A (en) * | 2008-07-15 | 2011-11-25 | Sanofi Aventis | Oxazolopyrimidines as edg-1 receptor agonists |
UY32240A (es) | 2008-11-14 | 2010-06-30 | Boeringer Ingelheim Kg | Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones. |
CN101899057A (zh) * | 2010-07-21 | 2010-12-01 | 中国药科大学 | 嘧啶并噁唑衍生物的一种制备方法及其在医学上的用途 |
US8907093B2 (en) * | 2011-07-07 | 2014-12-09 | Sanofi | Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
US8580816B2 (en) * | 2011-07-07 | 2013-11-12 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring |
CN103087077B (zh) * | 2011-11-03 | 2016-05-18 | 上海希迈医药科技有限公司 | 噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用 |
CN103360407B (zh) * | 2012-04-10 | 2016-06-22 | 上海希迈医药科技有限公司 | 一种噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用 |
WO2015162518A1 (en) | 2014-04-25 | 2015-10-29 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
CN104650111A (zh) * | 2015-01-14 | 2015-05-27 | 中国药科大学 | 芳基脲及芳基酰胺取代的噁唑并嘧啶类化合物及其制备和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137879A (en) | 1990-03-30 | 1992-08-11 | Dowelanco | Furopyrimidin-4-imine derivatives |
US5227387A (en) * | 1991-09-03 | 1993-07-13 | Dowelanco | Quinoline nematicidal method |
ATE159257T1 (de) * | 1994-05-03 | 1997-11-15 | Ciba Geigy Ag | Pyrrolopyrimidinderivate mit antiproliferativer wirkung |
JPH1184248A (ja) * | 1997-09-12 | 1999-03-26 | Nikon Corp | 反射屈折縮小光学系 |
EP1777218B1 (en) * | 2000-10-20 | 2008-12-31 | Eisai R&D Management Co., Ltd. | Process for the preparation of 4-phenoxy quinoline derivatives |
-
2002
- 2002-05-13 AT AT02740590T patent/ATE319718T1/de active
- 2002-05-13 DK DK02740590T patent/DK1390371T3/da active
- 2002-05-13 DE DE60209721T patent/DE60209721T2/de not_active Expired - Lifetime
- 2002-05-13 ES ES02740590T patent/ES2259707T3/es not_active Expired - Lifetime
- 2002-05-13 JP JP2002589487A patent/JP4155827B2/ja not_active Expired - Fee Related
- 2002-05-13 BR BR0209645-5A patent/BR0209645A/pt not_active IP Right Cessation
- 2002-05-13 CN CNB028100026A patent/CN100378107C/zh not_active Expired - Fee Related
- 2002-05-13 US US10/476,818 patent/US7294633B2/en not_active Expired - Fee Related
- 2002-05-13 CA CA002449188A patent/CA2449188A1/en not_active Abandoned
- 2002-05-13 PT PT02740590T patent/PT1390371E/pt unknown
- 2002-05-13 EP EP02740590A patent/EP1390371B1/en not_active Expired - Lifetime
- 2002-05-13 WO PCT/EP2002/005241 patent/WO2002092603A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BR0209645A (pt) | 2004-07-06 |
EP1390371B1 (en) | 2006-03-08 |
DE60209721T2 (de) | 2006-09-07 |
CA2449188A1 (en) | 2002-11-21 |
DK1390371T3 (da) | 2006-06-19 |
DE60209721D1 (de) | 2006-05-04 |
US20040152892A1 (en) | 2004-08-05 |
CN100378107C (zh) | 2008-04-02 |
CN1509291A (zh) | 2004-06-30 |
EP1390371A1 (en) | 2004-02-25 |
ATE319718T1 (de) | 2006-03-15 |
JP2005508855A (ja) | 2005-04-07 |
JP4155827B2 (ja) | 2008-09-24 |
WO2002092603A1 (en) | 2002-11-21 |
ES2259707T3 (es) | 2006-10-16 |
US7294633B2 (en) | 2007-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1390371E (pt) | Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores | |
DE50310516D1 (de) | Fredericamycin-derivate | |
ATE452129T1 (de) | N-phenyl-2-pyrimidine-amine derivatives | |
DE602004017194D1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
SE0101387D0 (sv) | Novel compounds | |
BR0308787A (pt) | Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona | |
DE602004027936D1 (de) | Tocopherolmodifizierte therapeutische arzneimittelverbindung | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
PA8571001A1 (es) | 2-(2,6-diclorofenil)-diarilimidazoles | |
ATE341550T1 (de) | Quinolinyl-pyrrolopyrazole | |
ATE448232T1 (de) | Substituierte heterozyklen | |
NO20050640L (no) | Rutenium anticancer komplekser | |
SE9900961D0 (sv) | Novel compounds | |
ATE396986T1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
SE9802208D0 (sv) | Novel compounds | |
DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
SE0300098D0 (sv) | Use of cyclin D1 inhibitors | |
EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
ATE368649T1 (de) | Cyanoguanidin prodrugs | |
SE9802209D0 (sv) | Novel compounds | |
TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
NO20055650D0 (no) | Ruteinum (II)-komplekser for behandling av tumorer | |
SE0004827D0 (sv) | Therapeutic compounds | |
PE20030236A1 (es) | Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados | |
ATE423780T1 (de) | Makrozyclen zur behandlung von krebserkrankungen |